Bayer's Expert Mondays - Knowledge Sharing to Empower Your Innovation Journey

Theme: "Growing your innovation or startup: Why Early Market Access Planning is a Good Investment & 10-min. deep-dive on Cell & Gene"

The divergence in evidence requirements betweent regulators. Health Techology Assessment Bodies, or Payers can create a challenging situation for manufacturers. Balancing the needs of both parties becomes crucial, especially when pivotal clinical trials are already underway. In such circumstances, there is limited flexibility to make adjustments or address potential evidence requirements that can unlolck the product's true potential in pricing and reimbursement.

Register here!

More information